 |
인쇄하기
취소
|
Local drug makers win patent nullification trial over Plavix
On June 28, a patent trial board ruled against Plavix (clopidogrel) patent in its nullification trial which had been sought by some local pharmaceutical firms.
Plavix is an anti-clotting agent that is the world's second-best-selling drug whose re-examination period already expired in Korea on July 6, 2005.
The court said in its ruling that Plavix patent owned by Sanofi-Aventis Korea is b...
Plavix is an anti-clotting agent that is the world's second-best-selling drug whose re-examination period already expired in Korea on July 6, 2005.
The court said in its ruling that Plavix patent owned by Sanofi-Aventis Korea is b...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.